Exam 29: Hiv- and Aids-Related Drugs
Exam 1: The Nursing Process and Patient-Centered Care15 Questions
Exam 2: Drug Development and Ethical Considerations23 Questions
Exam 3: Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics41 Questions
Exam 4: Pharmacogenetics9 Questions
Exam 5: Complementary and Alternative Therapies13 Questions
Exam 6: Pediatric Considerations17 Questions
Exam 7: Geriatric Considerations14 Questions
Exam 8: Drugs of Abuse15 Questions
Exam 9: Safety and Quality16 Questions
Exam 10: Drug Administration14 Questions
Exam 11: Drug Calculations22 Questions
Exam 12: Fluid Volume and Electrolytes22 Questions
Exam 13: Vitamin and Mineral Replacement20 Questions
Exam 14: Nutritional Support19 Questions
Exam 15: Adrenergic Agonists and Antagonists16 Questions
Exam 16: Cholinergic Agonists and Antagonists17 Questions
Exam 17: Stimulants12 Questions
Exam 18: Depressants18 Questions
Exam 19: Antiseizure Drugs20 Questions
Exam 20: Drugs for Parkinson Disease and Alzheimer Disease17 Questions
Exam 21: Drugs for Neuromuscular Disorders and Muscle Spasms16 Questions
Exam 22: Antipsychotics and Anxiolytics18 Questions
Exam 23: Antidepressants and Mood Stabilizers19 Questions
Exam 24: Antiinflammatories18 Questions
Exam 25: Analgesics17 Questions
Exam 26: Antibacterials48 Questions
Exam 27: Antituberculars, Antifungals, and Antivirals23 Questions
Exam 28: Peptides, Antimalarials, and Anthelmintics9 Questions
Exam 29: Hiv- and Aids-Related Drugs11 Questions
Exam 30: Transplant Drugs5 Questions
Exam 31: Vaccines11 Questions
Exam 32: Anticancer Drugs10 Questions
Exam 33: Targeted Therapies to Treat Cancer9 Questions
Exam 34: Biologic Response Modifiers11 Questions
Exam 35: Upper Respiratory Disorders11 Questions
Exam 36: Lower Respiratory Disorders15 Questions
Exam 37: Cardiac Glycosides, Antianginals, and Antidysrhythmics19 Questions
Exam 38: Diuretics11 Questions
Exam 39: Antihypertensives14 Questions
Exam 40: Anticoagulants, Antiplatelets, and Thrombolytics18 Questions
Exam 41: Antihyperlipidemics and Peripheral Vasodilators12 Questions
Exam 42: Gastrointestinal Tract Disorders18 Questions
Exam 43: Antiulcer Drugs14 Questions
Exam 44: Eye and Ear Disorders10 Questions
Exam 45: Dermatologic Disorders12 Questions
Exam 46: Pituitary, Thyroid, Parathyroid, and Adrenal Disorders21 Questions
Exam 47: Antidiabetics18 Questions
Exam 48: Urinary Disorders14 Questions
Exam 49: Pregnancy and Preterm Labor16 Questions
Exam 50: Labor, Delivery, and Postpartum13 Questions
Exam 51: Neonatal and Newborn5 Questions
Exam 52: Womens Reproductive Health17 Questions
Exam 53: Mens Reproductive Health11 Questions
Exam 54: Sexually Transmitted Infections7 Questions
Exam 55: Adult and Pediatric Emergency Drugs11 Questions
Select questions type
A patient will begin taking the protease inhibitor combination Kaletra (lopinavir/ritonavir). What information will the nurse include when teaching the patient about dietary changes?
Free
(Multiple Choice)
4.8/5
(80)
Correct Answer:
A
A patient who has HIV infection will begin treatment with efavirenz. The nurse expects this agent to be given in combination with other antiretrovirals in order to:
Free
(Multiple Choice)
4.8/5
(75)
Correct Answer:
C
A patient who will begin antiretroviral therapy reports having trouble sticking with drug regimens in the past. Which action will the nurse take?
Free
(Multiple Choice)
4.7/5
(73)
Correct Answer:
D
A pregnant patient is HIV-positive. Which of the following is true of antiretroviral therapy during pregnancy?
(Multiple Choice)
4.8/5
(77)
A patient who has recently begun antiretroviral therapy with a combination drug develops immune reconstitution inflammatory syndrome (IRIS) with mild symptoms. What does the nurse expect that the provider will recommend next?
(Multiple Choice)
4.9/5
(80)
The nurse is caring for a patient who is HIV-positive and has been receiving antiretroviral therapy for several months. The nurse experiences a needlestick injury resulting in exposure to the patient's blood. The nurse asks the Occupational Health nurse if treatment is necessary. How will the Occupational Health nurse respond?
(Multiple Choice)
4.9/5
(76)
A patient with HIV infection has been receiving antiretroviral therapy for 2 months. At the initiation of treatment, the patient had a viral load (VL) of 60 copies/mL and a CD4 count of 450 cells/mm3. Today's lab results reveal a VL of 20 copies/mL and a CD4 cell count of 800 cells/mm3. How will the nurse interpret the patient's results?
(Multiple Choice)
5.0/5
(81)
A patient who is HIV-infected takes 800 mg of indinavir (Crixivan), a protease inhibitor medication. The provider has ordered adding ritonavir (Norvir) to the regimen. The nurse will teach the patient that the addition of ritonavir:
(Multiple Choice)
4.8/5
(74)
A patient who is HIV-positive begins therapy with the fixed-dose combination nucleoside reverse transcriptase inhibitor (NRTI) Combivir (lamivudine/zidovudine) twice daily. The patient is in the clinic for follow-up 1 week after initiation of therapy and reports having nausea. The patient's creatinine clearance is 40 mL/minute. Based on these findings, the nurse will perform which action?
(Multiple Choice)
4.9/5
(93)
A patient who is newly diagnosed with HIV infection after a recent exposure calls to report fever, sore throat, myalgia, and night sweats. The nurse will notify the provider that this patient is most likely experiencing which of the following?
(Multiple Choice)
4.7/5
(80)
The nurse is caring for a 55-year-old patient who has been HIV-infected for 15 years. The nurse understands that this patient:
(Multiple Choice)
4.9/5
(69)
Filters
- Essay(0)
- Multiple Choice(0)
- Short Answer(0)
- True False(0)
- Matching(0)